Red de medicina de precisión en enfermedades complejas (RMPEC) - GIC 21/095
Hospital Universitario Central de Asturias
Oviedo, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Central de Asturias (12)
2023
-
Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders
Blood, Vol. 142, Núm. 5, pp. 434-445
-
Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing
International Journal of Molecular Sciences, Vol. 24, Núm. 22
2022
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
-
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis
European Journal of Internal Medicine, Vol. 105, pp. 30-37
-
Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children
Scientific Reports, Vol. 12, Núm. 1
2020
2018
-
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Oncologist, Vol. 23, Núm. 4, pp. 422-432
2014
-
Estudio multicéntrico nacional sobre la infección nosocomial en la UCIP
Anales de Pediatria, Vol. 80, Núm. 1, pp. 28-33
2013
2012
-
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease
Haematologica, Vol. 97, Núm. 4, pp. 616-621
2010
-
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE)
Annals of Oncology, Vol. 21, Núm. 9, pp. 1794-1803
2003
-
Autologous stem cell transplantation for primary refractory Hodgkin's disease: Results and clinical variables affecting outcome
Annals of Oncology, Vol. 14, Núm. 5, pp. 745-751